{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-25-004358","form_type":"8-K","ticker":"HRMY","cik":"0001802665","company_name":"Harmony Biosciences Holdings, Inc.","filed_at":"2025-04-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.775473+00:00","generated_at":"2026-05-23T22:44:16.434093+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Harmony Biosciences appoints Ron Philip to Board of Directors effective April 2, 2025","bullets":["Ron Philip, age 51, appointed as Class III director filling vacancy from Jack Bech Nielsen's resignation.","Philip will serve on the Audit Committee and Nominating and Corporate Governance Committee.","He is current CEO of Orbital Therapeutics and former CEO of Spark Therapeutics (April 2022–September 2024).","Philip has 30 years of biotech experience including roles at Pfizer, Wyeth, and Merck.","Board determined Philip qualifies as independent under Nasdaq standards; standard director compensation applies."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-25-004358","json":"https://secwatch.observer/filing/0001558370-25-004358.json","markdown":"https://secwatch.observer/filing/0001558370-25-004358.md","text":"https://secwatch.observer/filing/0001558370-25-004358.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1802665/000155837025004358/0001558370-25-004358-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1802665/000155837025004358/hrmy-20250402x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T22:44:16.434093+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"14d95571e0","claim":"Ron Philip was appointed as Class III director at Harmony Biosciences Holdings, Inc..","evidence_excerpt":"Effective April 2, 2025, the Board of Directors (the “Board”) of Harmony Biosciences Holdings, Inc. (the “Company”) appointed Ron Philip, age 51, as a Class III director, filling the previously announced vacancy in the Board created by the resignation of Jack Bech Nielsen effective June 27, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1802665/000155837025004358/0001558370-25-004358-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class III director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}